1887

Abstract

expresses different types of fimbriae simultaneously. Several fimbrial types have been described and their role in the colonization of the urinary tract is under study. Previously, fimbriae (PMF) have been shown to be associated with bacterial colonization of the lower urinary tract but not of the kidneys. In this study, a mutant was generated and used in several and studies. Two different urinary tract infection models in the mouse and two assays of bacterial adhesion to uroepithelial cells were performed. Expression of PmfA in a collection of strains of different sources was also assessed. The results shown here indicate that PMF are involved in both bladder and kidney colonization by and that these fimbriae are widely distributed among isolates from different origins since all strains tested expressed PmfA.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.26534-0
2003-11-01
2020-07-14
Loading full text...

Full text loading...

/deliver/fulltext/micro/149/11/mic1493231.html?itemId=/content/journal/micro/10.1099/mic.0.26534-0&mimeType=html&fmt=ahah

References

  1. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J.. 1990; Basic local alignment search tool. J Mol Biol215:403–410
    [Google Scholar]
  2. Bahrani F. K., Massad G., Lockatell C. V., Johnson D. E., Russell R. G., Warren J. W., Mobley H. L.. 1994; Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect Immun62:3363–3371
    [Google Scholar]
  3. Bullock W. O., Fernandez J. M., Short J. M.. 1987; XL1-Blue: a high efficiency plasmid transforming recA Escherichia coli strain with beta-galactosidase selection. Biotechniques5:376–379
    [Google Scholar]
  4. Donnenberg M. S., Kaper J. B.. 1991; Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun59:4310–4317
    [Google Scholar]
  5. Gruber A., Zingales B.. 1995; Alternative method to remove antibacterial antibodies from antisera used for screening of expression libraries. Biotechniques19:28
    [Google Scholar]
  6. Legnani-Fajardo C., Zunino P., Piccini C., Allen A. G., Maskell D. J.. 1996; Defined mutants of Proteus mirabilis lacking flagella cause ascending urinary tract infection. Microb Pathog21:395–405
    [Google Scholar]
  7. Li X., Mobley H. L.. 2002; Vaccines for Proteus mirabilis in urinary tract infection. Int J Antimicrob Agents19:461–465
    [Google Scholar]
  8. Li X., Lockatell C. V., Johnson D. E., Mobley H. L.. 2002; Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol Microbiol45:865–874
    [Google Scholar]
  9. Massad G., Mobley H. L. T.. 1994; Genetic organization and complete sequence of the Proteus mirabilis pmf fimbrial operon. Gene 150:101–104
    [Google Scholar]
  10. Massad G., Lockatell C. V., Johnson D. E., Mobley H. L. T.. 1994; Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection. Infect Immun62:536–542
    [Google Scholar]
  11. Mobley H. L. T., Belas R.. 1995; Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends Microbiol3:280–284
    [Google Scholar]
  12. Mobley H. L. T., Hausinger R. P.. 1989; Microbial ureases: significance, regulation, and molecular characterization. Microbiol Rev53:85–108
    [Google Scholar]
  13. Peerbooms P. G., Marian A., Verweij J. J., MacLaren D. M.. 1982; Urinary virulence of Proteus mirabilis in two experimental mouse models. Infect Immun36:1246–1248
    [Google Scholar]
  14. Pellegrino R., Galvalisi U., Scavone P., Sosa V., Zunino P.. 2003; Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. FEMS Immunol Med Microbiol36:103–110
    [Google Scholar]
  15. Piccini C. D., Barbé F. M., Legnani-Fajardo C. L.. 1998; Identification of iron-regulated outer membrane proteins in uropathogenic Proteus mirabilis and its relationship with heme uptake. FEMS Microbiol Lett166:243–248
    [Google Scholar]
  16. Rozalski A., Sidorczyk Z., Kotelko K.. 1997; Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev61:65–89
    [Google Scholar]
  17. Sambrook J., Fritsch E. F., Maniatis T.. 1989; Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
  18. Senior B. W.. 1979; The special affinity of particular types of Proteus mirabilis for the urinary tract. J Med Microbiol12:1–8
    [Google Scholar]
  19. Simon R., Priefer U., Puhler A.. 1983; A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Biotechnology1:784–791
    [Google Scholar]
  20. Stamm W. E., Martin S. M., Bennett J. V.. 1977; Epidemiology of nosocomial infections due to Gram negative bacilli: aspects relevant to development and use of vaccines. J Infect Dis136:S151–S160
    [Google Scholar]
  21. Studier F. W., Moffatt B. A.. 1986; Use of a bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol189:113–130
    [Google Scholar]
  22. Tolson D. L., Harrison B. A., Latta R. K., Lee K. K., Altman E.. 1997; The expression of nonagglutinating fimbriae and its role in Proteus mirabilis adherence to epithelial cells. Can J Microbiol43:709–717
    [Google Scholar]
  23. Vieira J., Messing J.. 1982; The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene19:259–268
    [Google Scholar]
  24. Warren J. W., Tenney J. H., Hoopes J. M., Kass E. H.. 1982; A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis146:719–723
    [Google Scholar]
  25. Wray S. K., Hull S. I., Cook R. G., Barrish J., Hull R. A.. 1986; Identification and characterization of a uroepithelial cell adhesin from a uropathogenic isolate of Proteus mirabilis. Infect Immun54:43–49
    [Google Scholar]
  26. Zunino P., Piccini C., Legnani-Fajardo C.. 1994; Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection. Microb Pathog16:379–385
    [Google Scholar]
  27. Zunino P., Geymonat L., Allen A. G., Legnani-Fajardo C., Maskell D. J.. 2000; Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection. FEMS Immunol Med Microbiol29:137–143
    [Google Scholar]
  28. Zunino P., Geymonat L., Allen A. G., Preston A., Sosa V., Maskell D. J.. 2001; New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection. FEMS Immunol Med Microbiol31:113–120
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.26534-0
Loading
/content/journal/micro/10.1099/mic.0.26534-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error